Gilead Sciences, Inc. (Nasdaq: GILD) awarded $7.6 million in grant funding to 24 U.S.-based, community organizations through the newly created Toward Health Equity (THE) Oncology Grantâ„¢. The funding will support evidence-based interventions that address barriers to care and social determinants of health including .